ArticleClinics (Sao Paulo, Brazil)2026
Development and validation of an explainable machine learning model for risk stratification in patients with clinically suspected acute pulmonary embolism: retrospective study.
Article in Clinics (Sao Paulo, Brazil), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAcute Pulmonary Embolism (APE) is a life-threatening cardiovascular emergency. Computed Tomography Pulmonary Angiography (CTPA) serves as the diagnostic gold standard but is associated with risks of overuse and radiation exposure.
objectiveTo develop and validate an explainable machine learning model for predicting the likelihood of APE in clinically suspected patients, aiming to optimize CTPA decision-making.
methodsThis study retrospectively enrolled 649 patients who underwent CTPA for suspected APE based on clinical symptoms, signs, or elevated D-dimer levels. Seventy-seven clinical variables were collected. Least Absolute Shrinkage and Selection Operator (LASSO) regression was used for initial feature screening, followed by multivariate logistic regression to identify independent predictors. Eight machine learning algorithms were compared to select the optimal model. The Shapley Additive exPlanations (SHAP) framework was applied for model interpretability analysis.
resultsThe model demonstrated stable performance in both training and validation sets (training set AUC: 0.865±0.003; validation set AUC: 0.843±0.038). In the independent test set, the logistic regression model achieved the best performance (AUC = 0.793). Thirteen key predictors were identified, including age, lactate, fibrin degradation products, and others. SHAP analysis visually illustrated the contribution of each feature to risk prediction.
conclusionsThe developed APE risk prediction model, based on logistic regression and SHAP interpretability, exhibits good discriminative ability and transparency. It shows potential for individualized risk stratification and optimization of CTPA utilization in clinical decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.